VISBY MEDICAL product recalled over labeling errors
- Recall date
- December 5, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- VISBY MEDICAL INC recalls visby medical COVID-19 Test kit *** An in vitro diagnostic for the qualitative detection of SARS-CoV-2 - Product Usage:…
- Recall number
- Z-0847-2021
- FDA classification
- Class II
- Brand / firm
- VISBY MEDICAL INC
- Sold / distributed
- U.S. Nationwide distribution including in the states of CA, DC, FL, GA, MD, MN, MT, VA, and WA. O.U.S.: None
Why it was recalled
Two issues: 1) 5 Lots were found to have incorrect labeling on the outer box stating that the product is CLIA Waived. 2) 3 Lots contain a kit component that expires prior to the expiration date on the test kits.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
visby medical COVID-19 Test kit *** An in vitro diagnostic for the qualitative detection of SARS-CoV-2 - Product Usage: The Visby Medical COVID-19 Test is only for use under the Food and Drug Administration s Emergency Use Authorization.
Get recall alerts
Free email alert whenever VISBY MEDICAL INC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VISBY MEDICAL INC